AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 82 filers reported holding AGILE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $258,000 | -5.8% | 90,000 | 0.0% | 0.00% | -33.3% |
| Q3 2020 | $274,000 | +9.6% | 90,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $250,000 | +49.7% | 90,000 | 0.0% | 0.00% | +50.0% |
| Q1 2020 | $167,000 | -16.5% | 90,000 | +12.5% | 0.00% | 0.0% |
| Q4 2019 | $200,000 | +110.5% | 80,000 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $95,000 | -18.8% | 80,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $117,000 | -3.3% | 80,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $121,000 | +163.0% | 80,000 | 0.0% | 0.00% | – |
| Q4 2018 | $46,000 | +58.6% | 80,000 | 0.0% | 0.00% | – |
| Q3 2018 | $29,000 | -27.5% | 80,000 | 0.0% | 0.00% | – |
| Q2 2018 | $40,000 | -80.6% | 80,000 | 0.0% | 0.00% | -100.0% |
| Q1 2018 | $206,000 | -76.1% | 80,000 | -75.1% | 0.00% | -83.3% |
| Q4 2017 | $863,000 | -79.9% | 320,682 | -66.6% | 0.01% | -78.6% |
| Q3 2017 | $4,286,000 | +14.4% | 961,082 | -3.8% | 0.03% | +12.0% |
| Q2 2017 | $3,745,000 | +18.3% | 998,582 | +1.1% | 0.02% | +19.0% |
| Q1 2017 | $3,165,000 | +72.1% | 987,582 | +206.1% | 0.02% | +75.0% |
| Q4 2016 | $1,839,000 | -18.3% | 322,582 | 0.0% | 0.01% | -20.0% |
| Q3 2016 | $2,252,000 | -27.4% | 322,582 | -20.9% | 0.02% | -25.0% |
| Q2 2016 | $3,102,000 | +53.6% | 407,582 | +25.3% | 0.02% | +53.8% |
| Q1 2016 | $2,020,000 | -30.4% | 325,248 | +9.3% | 0.01% | -23.5% |
| Q4 2015 | $2,904,000 | +44.8% | 297,582 | 0.0% | 0.02% | +54.5% |
| Q3 2015 | $2,006,000 | -21.5% | 297,582 | 0.0% | 0.01% | 0.0% |
| Q2 2015 | $2,556,000 | -39.4% | 297,582 | -34.6% | 0.01% | -31.2% |
| Q1 2015 | $4,220,000 | +51.0% | 455,282 | 0.0% | 0.02% | +60.0% |
| Q4 2014 | $2,795,000 | +16.3% | 455,282 | +38.3% | 0.01% | +25.0% |
| Q3 2014 | $2,403,000 | -18.1% | 329,182 | -2.1% | 0.01% | -11.1% |
| Q2 2014 | $2,933,000 | – | 336,382 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 2,123,567 | $12,104,000 | 41.30% |
| ProQuest Associates IV LLC | 5,062,363 | $28,856,000 | 8.17% |
| Vivo Capital, LLC | 1,513,975 | $8,630,000 | 2.84% |
| Aisling Capital LLC | 1,804,933 | $10,288,000 | 2.39% |
| INVESTOR AB | 3,510,189 | $20,008,000 | 1.46% |
| AlpInvest Partners B.V. | 27,693 | $158,000 | 0.56% |
| Cormorant Asset Management, LP | 563,880 | $3,214,000 | 0.43% |
| PURA VIDA INVESTMENTS, LLC | 164,501 | $938,000 | 0.34% |
| Perceptive Advisors | 661,446 | $3,770,000 | 0.27% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 140,000 | $799,000 | 0.20% |